a fiba nd glutathione & Diabetes: How the Body's Master Antioxidant and protecting cells from daily oxidative burden Return Healthy Glutathione Symmetry Capsules

doi: 10.1038/sj.bmt.1703612 19 NguyenL.FullerD.LennonS.LegerF.PuozzoC

The compound upregulates miR-200c-3p and miR-125b-5p by two- or three-fold, suppressing mesenchymal markers and inducing apoptosis through the modulation of the Bcl-2/Bax ratio modulation (Figure 3)

2010;20:S8594

Comparison with Similar Peptides GHK-Cu (Current) Half-Life:~2 hours Dosage:1-2 mg daily Administration:Topical or subcutaneous Research Status: Preclinical/Experimental Half-Life:~4 hours Dosage:200-500 mcg daily Administration:Subcutaneous injection Research Status: Preclinical/Experimental Half-Life:~2-3 days Dosage:2-5 mg per week Administration:Subcutaneous injection Research Status: Preclinical/Experimental Half-Life:~2-3 hours Dosage:2-4 IU daily Administration:Subcutaneous injection Research Status: FDA Approved (for specific conditions) Half-Life:~24 hours Dosage:10-25 mg daily Administration:Oral Research Status: Experimental Half-Life:~12 minutes Dosage:1-2 mg daily Administration:Subcutaneous injection Research Status: FDA Approved (for specific conditions) Highlighted rowcard shows the current peptide

Titmarsh HF, O'Connor R, Dhaliwal K, Akram AR